Endothelial Damage in Major Spine Surgery, Measured by Circulating Syndecan-1: an Observational Study.(GlycOrtho)

ConditionSpinal Fusion
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12-75
SponsorIstituto Ortopedico Rizzoli

About this trial

The goal of this observational study is to learn about endothelial damage in major spine surgery, expressed as rise in circulating Syndecan-1.

The main questions it aims to answer are:

* What is the extent of endothelial glycocalyx shedding in major spine surgery? * Are there differences in different type of surgical populations? (adolescent idiopathic scoliosis, adult degenerative spine disease, oncologic surgery)

To do so, blood samples will be drawn from participants at the following timepoints:

* basal * after surgery * if transfusion of Fresh Frozen Plasma: before and after transfusion * Post-Operative Day 1-2-4

Eligibility criteria

Qualifiers

Undergoing Major Spine Surgery with estimated blood loss> 25% of total blood volume

American Society of Anesthesiology status 1-2-3

Able to comprehend and sign informed consent.

If age <18 years: parent or legal representative able to comprehend and sign informed consent

Disqualifiers

Surgery outside of laboratory opening hours

Patients undergoing spine surgery for genetic syndromes/neuromuscular scoliosis

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators